Drugs Made In America Acquisition Corp.

Last updated September 27, 2026

Organization details

Legal name
Drugs Made In America Acquisition Corp.
Ownership
Public
Status
Active
Sector (GICS)
Financials
SIC code
6770 — Blank Checks
Headquarters city
New York
Headquarters state / province
New York
Headquarters country
United States
Fiscal year end
December
Ticker symbol
DMAA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002028614

Board of directors

Chief executives

Lynn Stockwell · CEO and Exe. Chair of Board
Since January 2025

Board connections

4 of this board's directors also sit on 1 other board. 1 is in the same sector.

Network of Drugs Made In America Acquisition Corp.'s board connections Drugs Made In America Acquisition II Corp. Drugs Made In America... Catherine Do Catherine Do Lynn Stockwell Lynn Stockwell Myron W. Shulgan Myron W. Shulgan Sridhar G. Prasad Sridhar G. Prasad Drugs Made In America Acqu...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Feb 18, 2025 Drugs Made In America Acquisition LLC 10% owner Open-market purchase +30,000 — —
Feb 18, 2025 Lynn Stockwell Director, Officer (CEO and Exe. Chair of Board), 10% owner Open-market purchase +30,000 — —
Jan 29, 2025 Drugs Made In America Acquisition LLC 10% owner Open-market purchase +400,000 — —
Jan 29, 2025 Lynn Stockwell Director, Officer (CEO and Executive COB), 10% owner Open-market purchase +400,000 — —
Jan 29, 2025 Myron W. Shulgan Director Other +100,000 — —
Jan 29, 2025 Sridhar G. Prasad Director Other +100,000 — —
Jan 29, 2025 Catherine Do Director Other +100,000 — —
Jan 29, 2025 Worman Glenn C. Officer (CFO) Other +100,000 — —
Jan 29, 2025 Drugs Made In America Acquisition LLC 10% owner Other −400,000 — —
Jan 29, 2025 Lynn Stockwell Director, Officer (CEO and Executive COB), 10% owner Other −400,000 — —
Jan 29, 2025 Drugs Made In America Acquisition LLC 10% owner Open-market sale −5,698,363 — —
Jan 29, 2025 Lynn Stockwell Director, Officer (CEO and Executive COB), 10% owner Open-market sale −5,698,363 — —

Organizations in the same sector, closest in location and size first.

Questions about Drugs Made In America Acquisition Corp.

Who is the CEO of Drugs Made In America Acquisition Corp.?

Lynn Stockwell has been Drugs Made In America Acquisition Corp.'s CEO and Exe. Chair of Board since January 2025.

How many directors are on Drugs Made In America Acquisition Corp.'s board?

Drugs Made In America Acquisition Corp.'s board has 4 directors: Catherine Do, Lynn Stockwell, Myron W. Shulgan and Sridhar G. Prasad.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="drugs-made-in-america-acquisition-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.